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asthma need to be appraised critically. For
example, the number of admissions to hospital is
often used as evidence of bad care of asthma in
general practice. Admission to hospital may,
however, often be appropriate. If we can remove
the stigma attached to admissions for acute asthma
generated by general practitioners junior hospital
doctors may take our referrals for admission more
seriously.
MARK LEVY
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AUTHOR'S REPLY,-I did show an increase in the
number of peak flow recordings obtained post-
clinic, although these were well short of the agreed
standard of 100%. We hope to achieve our agreed
standard before the audit cycle is repeated.
The clinic is run by a trained asthma nurse.
We now prescribe peak flow meters for all our
asthmatic patients, but this was possible only after
the clinic had started. We are educating our
patients about how to manage an acute attack on
the basis of their own serial peak flow readings.
I did not include a definition of asthma in my
paper as it was adequately defined in one of my
references, and this is the working definition that
we use.' The term known asthmatic patients
diagnosed in 1989 refers to those patients identified
as asthmatic by one of the doctors in our practice at
some previous time, based on commonly accepted
criteria in the history and physical examination but
not necessarily on more objective measurements
such as serial peak flow readings and reversibility
tests. The increased proportion of asthmatic
patients entered in the computer post-clinic largely
represents previously known asthmatic patients
not clearly identified as such before the asthma
clinic was started.
Finally, the numbers of admissions to hospital
that I recorded pre-clinic and post-clinic are too
small for any worthwhile comment to be made on
that aspect of the audit, although I agree that no
general practitioner should hesitate to recommend
admission for patients with acute asthma if in his or
her clinical judgment this is appropriate.
CEDRICK R MARTYS
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Site for immunising infants
SIR,-I do not agree with Angus Nicoll about the
accepted site for immunising infants in general
practice.'
I and colleagues conducted a most thorough
search of published reports, both clinical and
medicolegal, and consulted every leading authority
during a dispute that we had with our local health
authority over this matter in 1984.' Paediatricians
advised us that this was not a matter for specialist
pronouncement but one in which general prac-
titioners had most experience. The Medical
Defence Union, after giving a knee jerk warning
against using the buttock, consulted its records for
instances of injury. It reported 22 cases: 17 injuries
to the radial nerve and five to the sciatic nerve,
none of which had occurred in infants. Baraff et al
showed that local reactions, notably pain and
swelling, were more common after immunisation
in the thigh.3 Bergeson et al stated that the most
common serious complications of intramuscular
injections in children were muscle contractures
and nerve injuries,4 most of which were radial
nerve palsies. Some children have required excision
of fibrous tissue and lengthening of the triceps.
How did the strong fear of the sciatic nerve
arise? Gilles and French showed from studies on
young animals that penetration of the sciatic nerve
did not cause palsy.5 Nor was palsy due to
ischaemia from interruption of the vascular supply
or to intraneural haemorrhage. The final conclusion
reached was that substances injected, such as
streptomycin, antitoxins, bismuth, and quinine,
were neurotoxic. But measles, mumps, and rubella
vaccine is not neurotoxic, and in any case the
sciatic nerve cannot be reached with the 16 mm
needle used now, even in a test on a stillborn infant
weighing 2000 g.
The infant prone across the mother's lap provides
the most stable position for mother, baby, and
doctor. Most important, the child does not observe
the assault.
Finally, with regard to Nicoll's comment about
effective absorption, we were given expert advice
against rapid absorption: the child's immune
system is immature, and, unlike a brush antigen
without cells like hepatitis B vaccine, diphtheria,
tetanus, and pertussis vaccine needs to be absorbed
slowly. I hope that the buttock will become the
preferred site for injections before the age of 1 year.
M KEITH THOMPSON
Croydon CR0 5QS
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High dose triazolam and
anterograde amnesia
SIR,-In the context of the controversy surround-
ing the safety of the hypnotic benzodiazepine
triazolaml"I we report the findings of an unpub-
lished study performed in 1977, which support a
relation between the dose of triazolam and the
incidence of anterograde amnesia.
We studied 44 psychiatric patients admitted to
the emergency psychiatric department of Liege
University Hospital with symptoms related to
personality disorders (n=26), psychoses (n=10),
and adjustment disorders (n=8). There were
20 men and 24 women aged 17-66 (mean (SD) 35-4
(12-8) years). With their informed consent patients
received triazolam 2 mg at bedtime for their acute
insomnia for 1-19 days (mean 4-2 (3-6) days). No
other psychotropic drugs were given. The patients'
behaviour at night was observed by the psychiatric
resident on call (P-FP or DS) as well as by the
nursing staff. An independent resident interviewed
the patients the next morning to assess their
memory of the behaviour observed during the
night.
Twenty two patients did at least one thing at
night that they could not remember subsequently.
The most common event was nocturnal bulimia
(n= 13): patients ate some of their own sweets or
took their neighbours' supply or emptied the unit's
fridge. Other motor behaviour was observed in six
cases, from simple walking in the corridor or
making telephone calls to leaving the unit and, in
one case, driving a car and returning several hours
later. Six patients showed increased anxiety with
typical panic attacks, and five patients verbalised
suicidal thoughts, which did not appear in their
history or in the assessment performed the previous
day or the next morning. Suicide attempts were
noted in four patients concurrently with the
suicidal ideation, and heteroaggressive acts in
two patients. None of the patients recalled these
adverse events during the interview the next
morning. The adverse events stopped in 21 patients
when triazolam was stopped.
This study shows an extremely high incidence of
amnesic adverse events associated with high
dose triazolam. Amnesic bulimia at night was so
common that we called it "the triazolam fridge
syndrome." Triazolam was first marketed in
Belgium in 1977. The normal recommended dose
then was 0 25-1 mg; we gave 2 mg. The recom-
mended dose now is 0-125-0-5 mg.
Several previous reports have described antero-
grade amnesia associated with triazolam at lower
doses, but with a much lower incidence.e'0 Our
study suggests that the dose of triazolam is a crucial
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Monitoring lithium treatment
SIR,-R F Kehoe and A J Mander report serum
lithium concentrations in excess of 1 05 mmol/l in
56 of 458 patients taking lithium during a one year
period and note that in one third of these cases the
doctor did not make any response within six
weeks.'
These findings, while giving cause for concern,
may in fact compare favourably with the practice in
parts of the country where no lithium register is
kept. Recently a lithium audit was carried out in
the department of psychiatry, North Manchester
General Hospital, a district general hospital
serving a catchment population of 200 000. Of
201 patients identified as taking lithium, the
case notes of 56 were selected at random for
examination. Of 37 patients who had been taking
lithium for three or more years, eight were found to
have had, during the year of audit, a serum lithium
concentration F1-3 mmol/l. In only five of these
cases was there evidence in the case notes of the
doctor having initiated any response.
Perhaps more worrying was the finding that, of
the 31 patients who had been started on lithium
within the previous five years, there was confirma-
tion in the case notes of there having been a prior
physical examination in 20, a medical history in 18,
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